BioVersys AG (SWX:BIOV)
Switzerland
· Delayed Price · Currency is CHF
23.90
+0.40 (1.70%)
At close: Dec 4, 2025
BioVersys AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 |
| Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Debt / Equity Ratio | 0.26 | 1.59 | 1.86 |
| Asset Turnover | - | 0.04 | - |
| Quick Ratio | 9.02 | 3.51 | 3.25 |
| Current Ratio | 9.24 | 3.56 | 3.59 |
| Return on Equity (ROE) | - | -194.40% | - |
| Return on Assets (ROA) | - | -33.87% | - |
| Return on Capital (ROIC) | - | -44.89% | - |
| Return on Capital Employed (ROCE) | -21.00% | -74.10% | -71.40% |
| Buyback Yield / Dilution | - | -11.60% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.